Family History of Cancers Increases Risk of Renal Cell Carcinoma in a Chinese Population

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Jonasch E, Agarwal N, et al. Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15:804–834. doi:10.6004/jnccn.2017.0100
   PubMed Web of Science ®Google Scholar
• Padala SA, Barsouk A, Thandra KC, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11:79–87. doi:10.14740/wjon1279
   PubMedGoogle Scholar
• Christensen MB, Wadt K, Jensen UB, et al. Exploring the hereditary background of renal cancer in Denmark. PLoS One. 2019;14:e0215725. doi:10.1371/journal.pone.0215725
   PubMed Web of Science ®Google Scholar
• Gansler T, Fedewa SA, Flanders WD, Pollack LA, Siegel DA, Jemal A. Prevalence of cigarette smoking among patients with different histologic types of kidney cancer. Cancer Epidemiol Biomarkers Prev. 2020;29:1406–1412. doi:10.1158/1055-9965.EPI-20-0015
   PubMed Web of Science ®Google Scholar
• Washio M, Mori M, Mikami K, et al. Risk factors for renal cell carcinoma in a Japanese population. Asian Pac J Cancer Prev. 2014;15:9065–9070. doi:10.7314/APJCP.2014.15.21.9065
   PubMedGoogle Scholar
• Greco F, Cirimele V, Mallio C, Zobel B, Grasso R. Increased visceral adipose tissue in male patients with clear cell renal cell carcinoma. Clin Cancer Investig J. 2018;7(4):132. doi:10.4103/ccij.ccij_62_18
   Web of Science ®Google Scholar
• Greco F, Mallio CA, Grippo R, et al. Increased visceral adipose tissue in male patients with non-clear cell renal cell carcinoma. Radiol Med. 2020;125:538–543. doi:10.1007/s11547-020-01146-6
   PubMed Web of Science ®Google Scholar
• Greco F, Quarta LG, Grasso RF, Beomonte Zobel B, Mallio CA. Increased visceral adipose tissue in clear cell renal cell carcinoma with and without peritumoral collateral vessels. Br J Radiol. 2020;93:20200334. doi:10.1259/bjr.20200334
   PubMed Web of Science ®Google Scholar
• Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Nat Rev Cancer. 2015;15(1):55–64. doi:10.1038/nrc3844
   PubMed Web of Science ®Google Scholar
• Verine J, Pluvinage A, Bousquet G, et al. Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol. 2010;58:701–710. doi:10.1016/j.eururo.2010.08.031
   PubMed Web of Science ®Google Scholar
• Woodward ER, Ricketts C, Killick P, et al. Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN. Clin Cancer Res. 2008;14:5925–5930. doi:10.1158/1078-0432.CCR-08-0608
   PubMed Web of Science ®Google Scholar
• Hemminki K, Li X. Age-specific familial risks for renal cell carcinoma with evidence on recessive heritable effects. Kidney Int. 2004;65:2298–2302. doi:10.1111/j.1523-1755.2004.00650.x
   PubMed Web of Science ®Google Scholar
• Chen T, Fallah M, Sundquist K, Liu H, Hemminki K. Risk of subsequent cancers in renal cell carcinoma survivors with a family history. Eur J Cancer. 2014;50:2108–2118. doi:10.1016/j.ejca.2014.05.003
   PubMed Web of Science ®Google Scholar
• Furuya M, Yao M, Tanaka R, et al. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dube syndrome. Clin Genet. 2016;90:403–412. doi:10.1111/cge.12807
   PubMed Web of Science ®Google Scholar
• Seo JY, Ahn JY, Keam B, et al. Genotypic and phenotypic characteristics of hereditary leiomyomatosis and renal cell cancer syndrome in Korean patients. Ann Lab Med. 2021;41:207–213. doi:10.3343/alm.2021.41.2.207
   PubMed Web of Science ®Google Scholar
• Delahunt B, Eble JN, Egevad L, Samaratunga H. Grading of renal cell carcinoma. Histopathology. 2019;74:4–17. doi:10.1111/his.13735
   PubMed Web of Science ®Google Scholar
• Becker A, Hickmann D, Hansen J, et al. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma–Impact on prognosis. Eur J Surg Oncol. 2016;42:419–425. doi:10.1016/j.ejso.2015.09.023
   PubMed Web of Science ®Google Scholar
• Patel PH, Chadalavada RS, Chaganti RS, Motzer RJ. Targeting von Hippel-Lindau pathway in renal cell carcinoma. Clin Cancer Res. 2006;12:7215–7220. doi:10.1158/1078-0432.CCR-06-2254
   PubMed Web of Science ®Google Scholar
• Forde C, Lim DHK, Alwan Y, et al. Hereditary leiomyomatosis and renal cell cancer: clinical, molecular, and screening features in a cohort of 185 affected individuals. Eur Urol Oncol. 2020;3:764–772. doi:10.1016/j.euo.2019.11.002
   PubMed Web of Science ®Google Scholar
• Xu Y, Huang D, Wu Y, et al. Family history is significantly associated with prostate cancer and its early onset in Chinese population. Prostate. 2019;79:1762–1766. doi:10.1002/pros.23900
   PubMed Web of Science ®Google Scholar
• Gausman V, Dornblaser D, Anand S, et al. Risk factors associated with early-onset colorectal cancer. Clin Gastroenterol Hepatol. 2020;18:2752–9 e2. doi:10.1016/j.cgh.2019.10.009
   PubMed Web of Science ®Google Scholar
• Gietel-Basten S, Han X, Cheng Y. Assessing the impact of the “one-child policy” in China: a synthetic control approach. PLoS One. 2019;14:e0220170. doi:10.1371/journal.pone.0220170
   PubMed Web of Science ®Google Scholar
• Wei W, Zeng H, Zheng R, et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 2020;21:e342–e9. doi:10.1016/S1470-2045(20)30073-5
   PubMed Web of Science ®Google Scholar
• Przybycin CG, Magi-Galluzzi C, McKenney JK. Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens. Adv Anat Pathol. 2013;20:245–263. doi:10.1097/PAP.0b013e318299b7c6
   PubMed Web of Science ®Google Scholar
• Agaimy A, Hartmann A. Uncovering hereditary tumor syndromes: emerging role of surgical pathology. Semin Diagn Pathol. 2018;35:154–160. doi:10.1053/j.semdp.2018.01.001
   PubMed Web of Science ®Google Scholar
• Sinicrope FA. Lynch syndrome-associated colorectal cancer. N Engl J Med. 2018;379:764–773. doi:10.1056/NEJMcp1714533
   PubMed Web of Science ®Google Scholar
• Biller LH, Syngal S, Yurgelun MB. Recent advances in Lynch syndrome. Fam Cancer. 2019;18:211–219. doi:10.1007/s10689-018-00117-1
   PubMed Web of Science ®Google Scholar
• Pellat A, Netter J, Perkins G, et al.  Syndrome de Lynch : quoi de neuf? [Lynch syndrome: what is new?]. Bull Cancer. 2019;106:647–655. French. doi:10.1016/j.bulcan.2018.10.009
   PubMed Web of Science ®Google Scholar
• Deguchi M, Shiina H, Igawa M, Kaneuchi M, Nakajima K, Dahiya R. DNA mismatch repair genes in renal cell carcinoma. J Urol. 2003;169:2365–2371. doi:10.1097/01.ju.0000065668.19267.b4
   PubMed Web of Science ®Google Scholar
• Stoehr C, Burger M, Stoehr R, et al. Mismatch repair proteins hMLH1 and hMSH2 are differently expressed in the three main subtypes of sporadic renal cell carcinoma. Pathobiology. 2012;79:162–168. doi:10.1159/000335642
   PubMed Web of Science ®Google Scholar
• Roslan NH, Makpol S, Mohd Yusof YA. A review on dietary intervention in obesity associated colon cancer. Asian Pac J Cancer Prev. 2019;20:1309–1319. doi:10.31557/APJCP.2019.20.5.1309
   PubMedGoogle Scholar